nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Dactinomycin—muscle cancer	0.18	0.258	CbGbCtD
Etravirine—ABCB1—Vincristine—muscle cancer	0.111	0.159	CbGbCtD
Etravirine—ABCB1—Etoposide—muscle cancer	0.101	0.146	CbGbCtD
Etravirine—ABCB1—Doxorubicin—muscle cancer	0.0692	0.0993	CbGbCtD
Etravirine—ABCB1—Methotrexate—muscle cancer	0.067	0.0962	CbGbCtD
Etravirine—CYP3A4—Vincristine—muscle cancer	0.0664	0.0952	CbGbCtD
Etravirine—CYP3A4—Etoposide—muscle cancer	0.0608	0.0872	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—muscle cancer	0.0415	0.0595	CbGbCtD
Etravirine—Erythema multiforme—Dactinomycin—muscle cancer	0.00193	0.00636	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00192	0.00634	CcSEcCtD
Etravirine—Blood disorder—Doxorubicin—muscle cancer	0.00182	0.00602	CcSEcCtD
Etravirine—Inflammation—Methotrexate—muscle cancer	0.00181	0.00599	CcSEcCtD
Etravirine—Bronchospasm—Etoposide—muscle cancer	0.00181	0.00598	CcSEcCtD
Etravirine—Hypoaesthesia—Vincristine—muscle cancer	0.00181	0.00598	CcSEcCtD
Etravirine—Urinary tract disorder—Vincristine—muscle cancer	0.0018	0.00593	CcSEcCtD
Etravirine—Connective tissue disorder—Vincristine—muscle cancer	0.00179	0.0059	CcSEcCtD
Etravirine—Urethral disorder—Vincristine—muscle cancer	0.00178	0.00589	CcSEcCtD
Etravirine—Cardiac disorder—Vincristine—muscle cancer	0.00169	0.00558	CcSEcCtD
Etravirine—Angiopathy—Vincristine—muscle cancer	0.00165	0.00545	CcSEcCtD
Etravirine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00165	0.00543	CcSEcCtD
Etravirine—Mediastinal disorder—Vincristine—muscle cancer	0.00164	0.00542	CcSEcCtD
Etravirine—Anaemia—Dactinomycin—muscle cancer	0.00164	0.00541	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00163	0.00538	CcSEcCtD
Etravirine—Acute coronary syndrome—Etoposide—muscle cancer	0.00162	0.00534	CcSEcCtD
Etravirine—Renal failure—Etoposide—muscle cancer	0.00161	0.00533	CcSEcCtD
Etravirine—Myocardial infarction—Etoposide—muscle cancer	0.00161	0.00531	CcSEcCtD
Etravirine—Neuropathy peripheral—Etoposide—muscle cancer	0.00161	0.00531	CcSEcCtD
Etravirine—Stomatitis—Etoposide—muscle cancer	0.0016	0.00529	CcSEcCtD
Etravirine—Malaise—Dactinomycin—muscle cancer	0.0016	0.00528	CcSEcCtD
Etravirine—Mental disorder—Vincristine—muscle cancer	0.00159	0.00526	CcSEcCtD
Etravirine—Gynaecomastia—Methotrexate—muscle cancer	0.00157	0.00519	CcSEcCtD
Etravirine—Inflammation—Doxorubicin—muscle cancer	0.00157	0.00518	CcSEcCtD
Etravirine—Hepatobiliary disease—Etoposide—muscle cancer	0.00155	0.00513	CcSEcCtD
Etravirine—Abnormal dreams—Doxorubicin—muscle cancer	0.00151	0.00497	CcSEcCtD
Etravirine—Discomfort—Dactinomycin—muscle cancer	0.00149	0.00492	CcSEcCtD
Etravirine—Diabetes mellitus—Methotrexate—muscle cancer	0.00147	0.00485	CcSEcCtD
Etravirine—Hypoaesthesia—Etoposide—muscle cancer	0.00147	0.00484	CcSEcCtD
Etravirine—Anaemia—Vincristine—muscle cancer	0.00146	0.00483	CcSEcCtD
Etravirine—Urinary tract disorder—Etoposide—muscle cancer	0.00146	0.00481	CcSEcCtD
Etravirine—Urethral disorder—Etoposide—muscle cancer	0.00145	0.00477	CcSEcCtD
Etravirine—Infection—Dactinomycin—muscle cancer	0.00144	0.00475	CcSEcCtD
Etravirine—Vertigo—Vincristine—muscle cancer	0.00142	0.0047	CcSEcCtD
Etravirine—Hepatic failure—Methotrexate—muscle cancer	0.00142	0.00469	CcSEcCtD
Etravirine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00142	0.00468	CcSEcCtD
Etravirine—Erythema multiforme—Etoposide—muscle cancer	0.00139	0.0046	CcSEcCtD
Etravirine—Renal failure acute—Methotrexate—muscle cancer	0.00138	0.00456	CcSEcCtD
Etravirine—Anorexia—Dactinomycin—muscle cancer	0.00138	0.00455	CcSEcCtD
Etravirine—Eye disorder—Etoposide—muscle cancer	0.00138	0.00455	CcSEcCtD
Etravirine—Convulsion—Vincristine—muscle cancer	0.00137	0.00453	CcSEcCtD
Etravirine—Cardiac disorder—Etoposide—muscle cancer	0.00137	0.00452	CcSEcCtD
Etravirine—Hypertension—Vincristine—muscle cancer	0.00137	0.00452	CcSEcCtD
Etravirine—Angiopathy—Etoposide—muscle cancer	0.00134	0.00442	CcSEcCtD
Etravirine—Immune system disorder—Etoposide—muscle cancer	0.00133	0.0044	CcSEcCtD
Etravirine—Mediastinal disorder—Etoposide—muscle cancer	0.00133	0.00439	CcSEcCtD
Etravirine—Infection—Vincristine—muscle cancer	0.00128	0.00424	CcSEcCtD
Etravirine—Diabetes mellitus—Doxorubicin—muscle cancer	0.00127	0.0042	CcSEcCtD
Etravirine—Nervous system disorder—Vincristine—muscle cancer	0.00127	0.00419	CcSEcCtD
Etravirine—Thrombocytopenia—Vincristine—muscle cancer	0.00127	0.00418	CcSEcCtD
Etravirine—Decreased appetite—Dactinomycin—muscle cancer	0.00126	0.00415	CcSEcCtD
Etravirine—Hyperhidrosis—Vincristine—muscle cancer	0.00125	0.00413	CcSEcCtD
Etravirine—Fatigue—Dactinomycin—muscle cancer	0.00125	0.00412	CcSEcCtD
Etravirine—Pain—Dactinomycin—muscle cancer	0.00124	0.00409	CcSEcCtD
Etravirine—Anorexia—Vincristine—muscle cancer	0.00123	0.00407	CcSEcCtD
Etravirine—Hepatic failure—Doxorubicin—muscle cancer	0.00123	0.00406	CcSEcCtD
Etravirine—Renal failure acute—Doxorubicin—muscle cancer	0.0012	0.00395	CcSEcCtD
Etravirine—Feeling abnormal—Dactinomycin—muscle cancer	0.00119	0.00394	CcSEcCtD
Etravirine—Ill-defined disorder—Etoposide—muscle cancer	0.00119	0.00393	CcSEcCtD
Etravirine—Anaemia—Etoposide—muscle cancer	0.00119	0.00392	CcSEcCtD
Etravirine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00118	0.00391	CcSEcCtD
Etravirine—Insomnia—Vincristine—muscle cancer	0.00117	0.00386	CcSEcCtD
Etravirine—Paraesthesia—Vincristine—muscle cancer	0.00116	0.00383	CcSEcCtD
Etravirine—Malaise—Etoposide—muscle cancer	0.00116	0.00382	CcSEcCtD
Etravirine—Dermatitis bullous—Doxorubicin—muscle cancer	0.00116	0.00382	CcSEcCtD
Etravirine—Breast disorder—Methotrexate—muscle cancer	0.00115	0.00381	CcSEcCtD
Etravirine—Vertigo—Etoposide—muscle cancer	0.00115	0.00381	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00115	0.0038	CcSEcCtD
Etravirine—Body temperature increased—Dactinomycin—muscle cancer	0.00114	0.00378	CcSEcCtD
Etravirine—Abdominal pain—Dactinomycin—muscle cancer	0.00114	0.00378	CcSEcCtD
Etravirine—Loss of consciousness—Etoposide—muscle cancer	0.00113	0.00372	CcSEcCtD
Etravirine—Decreased appetite—Vincristine—muscle cancer	0.00112	0.00371	CcSEcCtD
Etravirine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00112	0.00369	CcSEcCtD
Etravirine—Fatigue—Vincristine—muscle cancer	0.00111	0.00368	CcSEcCtD
Etravirine—Convulsion—Etoposide—muscle cancer	0.00111	0.00367	CcSEcCtD
Etravirine—Hypertension—Etoposide—muscle cancer	0.00111	0.00366	CcSEcCtD
Etravirine—Pain—Vincristine—muscle cancer	0.00111	0.00365	CcSEcCtD
Etravirine—Constipation—Vincristine—muscle cancer	0.00111	0.00365	CcSEcCtD
Etravirine—Eosinophilia—Methotrexate—muscle cancer	0.00109	0.00361	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00109	0.00358	CcSEcCtD
Etravirine—Pancreatitis—Methotrexate—muscle cancer	0.00108	0.00357	CcSEcCtD
Etravirine—Discomfort—Etoposide—muscle cancer	0.00108	0.00356	CcSEcCtD
Etravirine—Hypersensitivity—Dactinomycin—muscle cancer	0.00107	0.00352	CcSEcCtD
Etravirine—Gastrointestinal pain—Vincristine—muscle cancer	0.00106	0.00349	CcSEcCtD
Etravirine—Confusional state—Etoposide—muscle cancer	0.00106	0.00349	CcSEcCtD
Etravirine—Infection—Etoposide—muscle cancer	0.00104	0.00344	CcSEcCtD
Etravirine—Asthenia—Dactinomycin—muscle cancer	0.00104	0.00343	CcSEcCtD
Etravirine—Thrombocytopenia—Etoposide—muscle cancer	0.00103	0.00339	CcSEcCtD
Etravirine—Abdominal pain—Vincristine—muscle cancer	0.00102	0.00337	CcSEcCtD
Etravirine—Body temperature increased—Vincristine—muscle cancer	0.00102	0.00337	CcSEcCtD
Etravirine—Skin disorder—Etoposide—muscle cancer	0.00102	0.00336	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—muscle cancer	0.00101	0.00334	CcSEcCtD
Etravirine—Hyperhidrosis—Etoposide—muscle cancer	0.00101	0.00334	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—muscle cancer	0.000999	0.0033	CcSEcCtD
Etravirine—Anorexia—Etoposide—muscle cancer	0.000999	0.0033	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000995	0.00329	CcSEcCtD
Etravirine—Diarrhoea—Dactinomycin—muscle cancer	0.00099	0.00327	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—muscle cancer	0.000978	0.00323	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000975	0.00322	CcSEcCtD
Etravirine—Renal failure—Methotrexate—muscle cancer	0.000967	0.00319	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—muscle cancer	0.000962	0.00318	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—muscle cancer	0.000959	0.00317	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—muscle cancer	0.000956	0.00316	CcSEcCtD
Etravirine—Hypersensitivity—Vincristine—muscle cancer	0.000953	0.00315	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—muscle cancer	0.000946	0.00312	CcSEcCtD
Etravirine—Paraesthesia—Etoposide—muscle cancer	0.000941	0.00311	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—muscle cancer	0.000937	0.00309	CcSEcCtD
Etravirine—Somnolence—Etoposide—muscle cancer	0.000931	0.00307	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—muscle cancer	0.000931	0.00307	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—muscle cancer	0.00093	0.00307	CcSEcCtD
Etravirine—Asthenia—Vincristine—muscle cancer	0.000928	0.00306	CcSEcCtD
Etravirine—Vomiting—Dactinomycin—muscle cancer	0.00092	0.00304	CcSEcCtD
Etravirine—Rash—Dactinomycin—muscle cancer	0.000913	0.00301	CcSEcCtD
Etravirine—Decreased appetite—Etoposide—muscle cancer	0.000911	0.00301	CcSEcCtD
Etravirine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000904	0.00299	CcSEcCtD
Etravirine—Fatigue—Etoposide—muscle cancer	0.000903	0.00298	CcSEcCtD
Etravirine—Constipation—Etoposide—muscle cancer	0.000896	0.00296	CcSEcCtD
Etravirine—Pain—Etoposide—muscle cancer	0.000896	0.00296	CcSEcCtD
Etravirine—Diarrhoea—Vincristine—muscle cancer	0.000885	0.00292	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—muscle cancer	0.000883	0.00292	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—muscle cancer	0.000872	0.00288	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—muscle cancer	0.000866	0.00286	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—muscle cancer	0.000863	0.00285	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000862	0.00285	CcSEcCtD
Etravirine—Nausea—Dactinomycin—muscle cancer	0.00086	0.00284	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—muscle cancer	0.000857	0.00283	CcSEcCtD
Etravirine—Dizziness—Vincristine—muscle cancer	0.000855	0.00282	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000845	0.00279	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—muscle cancer	0.000837	0.00276	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—muscle cancer	0.000835	0.00276	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000835	0.00276	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—muscle cancer	0.00083	0.00274	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—muscle cancer	0.000828	0.00273	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—muscle cancer	0.000828	0.00273	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—muscle cancer	0.000828	0.00273	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—muscle cancer	0.000825	0.00272	CcSEcCtD
Etravirine—Vomiting—Vincristine—muscle cancer	0.000822	0.00271	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—muscle cancer	0.00082	0.00271	CcSEcCtD
Etravirine—Rash—Vincristine—muscle cancer	0.000815	0.00269	CcSEcCtD
Etravirine—Dermatitis—Vincristine—muscle cancer	0.000815	0.00269	CcSEcCtD
Etravirine—Headache—Vincristine—muscle cancer	0.00081	0.00267	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000806	0.00266	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—muscle cancer	0.000801	0.00265	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—muscle cancer	0.000798	0.00263	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—muscle cancer	0.000796	0.00263	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—muscle cancer	0.000774	0.00255	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—muscle cancer	0.000772	0.00255	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—muscle cancer	0.000769	0.00254	CcSEcCtD
Etravirine—Nausea—Vincristine—muscle cancer	0.000768	0.00254	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—muscle cancer	0.000765	0.00252	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000761	0.00251	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000755	0.00249	CcSEcCtD
Etravirine—Asthenia—Etoposide—muscle cancer	0.000752	0.00248	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000752	0.00248	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—muscle cancer	0.00075	0.00247	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—muscle cancer	0.000725	0.00239	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—muscle cancer	0.000723	0.00239	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—muscle cancer	0.000717	0.00237	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—muscle cancer	0.000715	0.00236	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—muscle cancer	0.000713	0.00235	CcSEcCtD
Etravirine—Anaemia—Methotrexate—muscle cancer	0.000711	0.00235	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—muscle cancer	0.00071	0.00234	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—muscle cancer	0.000694	0.00229	CcSEcCtD
Etravirine—Malaise—Methotrexate—muscle cancer	0.000693	0.00229	CcSEcCtD
Etravirine—Dizziness—Etoposide—muscle cancer	0.000693	0.00229	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—muscle cancer	0.000691	0.00228	CcSEcCtD
Etravirine—Vertigo—Methotrexate—muscle cancer	0.000691	0.00228	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000689	0.00228	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—muscle cancer	0.00067	0.00221	CcSEcCtD
Etravirine—Convulsion—Methotrexate—muscle cancer	0.000666	0.0022	CcSEcCtD
Etravirine—Vomiting—Etoposide—muscle cancer	0.000666	0.0022	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—muscle cancer	0.000666	0.0022	CcSEcCtD
Etravirine—Rash—Etoposide—muscle cancer	0.000661	0.00218	CcSEcCtD
Etravirine—Dermatitis—Etoposide—muscle cancer	0.00066	0.00218	CcSEcCtD
Etravirine—Headache—Etoposide—muscle cancer	0.000656	0.00217	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—muscle cancer	0.000656	0.00217	CcSEcCtD
Etravirine—Tension—Doxorubicin—muscle cancer	0.000653	0.00216	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00065	0.00215	CcSEcCtD
Etravirine—Discomfort—Methotrexate—muscle cancer	0.000647	0.00213	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—muscle cancer	0.000647	0.00213	CcSEcCtD
Etravirine—Confusional state—Methotrexate—muscle cancer	0.000633	0.00209	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—muscle cancer	0.000627	0.00207	CcSEcCtD
Etravirine—Infection—Methotrexate—muscle cancer	0.000623	0.00206	CcSEcCtD
Etravirine—Nausea—Etoposide—muscle cancer	0.000622	0.00205	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000618	0.00204	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—muscle cancer	0.000615	0.00203	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—muscle cancer	0.000615	0.00203	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—muscle cancer	0.000614	0.00203	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—muscle cancer	0.000609	0.00201	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—muscle cancer	0.000607	0.002	CcSEcCtD
Etravirine—Malaise—Doxorubicin—muscle cancer	0.0006	0.00198	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—muscle cancer	0.000598	0.00197	CcSEcCtD
Etravirine—Anorexia—Methotrexate—muscle cancer	0.000598	0.00197	CcSEcCtD
Etravirine—Syncope—Doxorubicin—muscle cancer	0.000597	0.00197	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—muscle cancer	0.000585	0.00193	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—muscle cancer	0.000577	0.0019	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—muscle cancer	0.000575	0.0019	CcSEcCtD
Etravirine—Insomnia—Methotrexate—muscle cancer	0.000568	0.00187	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—muscle cancer	0.000565	0.00186	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—muscle cancer	0.000563	0.00186	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000563	0.00186	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—muscle cancer	0.00056	0.00185	CcSEcCtD
Etravirine—Somnolence—Methotrexate—muscle cancer	0.000558	0.00184	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—muscle cancer	0.000554	0.00183	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—muscle cancer	0.000548	0.00181	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—muscle cancer	0.000545	0.0018	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000542	0.00179	CcSEcCtD
Etravirine—Fatigue—Methotrexate—muscle cancer	0.000541	0.00179	CcSEcCtD
Etravirine—Infection—Doxorubicin—muscle cancer	0.00054	0.00178	CcSEcCtD
Etravirine—Pain—Methotrexate—muscle cancer	0.000537	0.00177	CcSEcCtD
Etravirine—Shock—Doxorubicin—muscle cancer	0.000535	0.00176	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—muscle cancer	0.000533	0.00176	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000532	0.00176	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—muscle cancer	0.000528	0.00174	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000525	0.00173	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—muscle cancer	0.000518	0.00171	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—muscle cancer	0.000517	0.00171	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000513	0.00169	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—muscle cancer	0.000496	0.00164	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—muscle cancer	0.000496	0.00164	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—muscle cancer	0.000491	0.00162	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—muscle cancer	0.000488	0.00161	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—muscle cancer	0.000483	0.00159	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—muscle cancer	0.000472	0.00156	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000469	0.00155	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—muscle cancer	0.000468	0.00155	CcSEcCtD
Etravirine—Pain—Doxorubicin—muscle cancer	0.000465	0.00153	CcSEcCtD
Etravirine—Constipation—Doxorubicin—muscle cancer	0.000465	0.00153	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—muscle cancer	0.000462	0.00153	CcSEcCtD
Etravirine—Asthenia—Methotrexate—muscle cancer	0.00045	0.00149	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—muscle cancer	0.000448	0.00148	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000444	0.00147	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—muscle cancer	0.00043	0.00142	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—muscle cancer	0.00043	0.00142	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—muscle cancer	0.000429	0.00142	CcSEcCtD
Etravirine—Dizziness—Methotrexate—muscle cancer	0.000415	0.00137	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—muscle cancer	0.0004	0.00132	CcSEcCtD
Etravirine—Vomiting—Methotrexate—muscle cancer	0.000399	0.00132	CcSEcCtD
Etravirine—Rash—Methotrexate—muscle cancer	0.000396	0.00131	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—muscle cancer	0.000395	0.0013	CcSEcCtD
Etravirine—Headache—Methotrexate—muscle cancer	0.000393	0.0013	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—muscle cancer	0.00039	0.00129	CcSEcCtD
Etravirine—Nausea—Methotrexate—muscle cancer	0.000373	0.00123	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—muscle cancer	0.000372	0.00123	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—muscle cancer	0.000359	0.00119	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—muscle cancer	0.000345	0.00114	CcSEcCtD
Etravirine—Rash—Doxorubicin—muscle cancer	0.000343	0.00113	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—muscle cancer	0.000342	0.00113	CcSEcCtD
Etravirine—Headache—Doxorubicin—muscle cancer	0.00034	0.00112	CcSEcCtD
Etravirine—Nausea—Doxorubicin—muscle cancer	0.000323	0.00107	CcSEcCtD
